2Checkout Will Host the 9th Edition of CommerceNow Event, Inspiring Businesses to Amplify the Way They Sell Online
NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- 2Checkout, a global leader in payment and commerce solutions for cross-border digital sales, today announces that its highly anticipated 9th edition of CommerceNow, will take place on June 18-19, 2025. The premier event for eCommerce professionals, marketers, and business owners looking to expand their digital commerce capabilities will bring together industry leaders and innovators who will share market-tested insights to leap ahead in the landscape.
Across two content-packed days, 14 world-class speakers will be going over the latest industry trends while presenting actionable strategies to help businesses thrive in the online ecosystem. Hosted by Nataliya Shadykulova, Head of New Business EMEA at 2Checkout, CommerceNow 2025 promises an immersive, interactive experience designed to educate, inspire, and drive tangible results for attendees.
This year's key themes focus on essential topics for modern commerce success, including digital commerce innovation, customer acquisition and retention, AI-driven marketing strategies, and online payments and global expansion. Attendees can look forward to presentations from globally recognized eCommerce visionaries, including Jenn VandeZande, Head of Digital Engagement at SAP Customer Experience, Elise Marengo, Director of Customer Success at Engineer Up, Marc Uitterhoeve, CEO at Dexter Agency, and many others.
"CommerceNow 2025 captures the very essence of digital transformation and innovation in the online selling space," said Nataliya Shadykulova, Head of New Business at 2Checkout. "With the industry evolving at an unprecedented pace, this is the must-see event for merchants looking for the newest strategies that empower their businesses to adapt and thrive. At 2Checkout, we are committed to inspiring meaningful change in the commerce space, and CommerceNow is a reflection of that commitment—bringing together thought leaders, cutting-edge ideas, and practical solutions to help shape the future of eCommerce."
Visit the CommerceNow'25 event page to sign up for free and unlock insights to boost business performance. Participants will also have access to valuable on-demand recordings post-event to revisit key takeaways and implement strategies at their own pace.
About 2Checkout
Verifone's 2Checkout platform is an all-in-one digital sales optimization solution that drives sales growth across online channels while managing the sales process from end-to-end to allow clients to focus on innovation and delivering exceptional customer experiences. Learn more at 2Checkout.com.
press@verifone.com
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/1a7ec5db-c972-4555-87a9-02e9f03e5c05Sign in to access your portfolio
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 minutes ago
- Yahoo
Alpayana Completes Privatization of Sierra Metals Inc.
TORONTO, Aug. 1, 2025 /CNW/ - Alpayana S.A.C. ("Alpayana") and Sierra Metals Inc. ("Amalco") announce today that Alpayana has completed the privatization of Sierra Metals Inc. ("Sierra"). The privatization was completed pursuant to the amalgamation (the "Amalgamation") of Sierra and 17199279 Canada Inc. ("Subco"), a wholly-owned subsidiary of Sierra, and related transactions. The amalgamated company resulting from the Amalgamation (being Amalco) has retained the name "Sierra Metals Inc.". The Amalgamation constituted the "subsequent acquisition transaction" contemplated by the offer ("Offer") of Alpayana Canada Ltd. ("Alpayana Canada") to acquire all of the issued and outstanding common shares of Sierra (the "Sierra Shares") that expired on May 23, 2025. Pursuant to the Amalgamation, (i) holders of Sierra Shares ("Sierra Shareholders") (other than Alpayana Canada) received one Series A preferred share of Amalco (each, an "Amalco Preferred Share"); and (ii) Alpayana Canada received one common share of Amalco (each, an "Amalco Common Share"), in each case for each Sierra Share held prior to the Amalgamation. Following completion of the Amalgamation, there are 13,367,340 Amalco Preferred Shares and 202,768,502 Amalco Common Shares issued and outstanding. In accordance with the terms of the Amalco Preferred Shares, Alpayana Canada exercised its right to acquire such shares, and following the completion of the Amalgamation, Alpayana Canada acquired all of the Amalco Preferred Shares (the "Preferred Share Acquisition") for consideration per Amalco Preferred Share of C$1.15 in cash (the "Consideration"), less any applicable withholdings. The Consideration is the same form and same amount of consideration offered to Sierra Shareholders under the Offer. Following completion of the Preferred Share Acquisition, Amalco became a wholly-owned subsidiary of Alpayana Canada. It is expected that the Sierra Shares will be delisted from the Toronto Stock Exchange at the close of trading on August 6, 2025. In addition, Amalco will make an application to the Ontario Securities Commission, as principal regulator, and to the securities regulatory authorities in each of the other provinces in Canada in which it is a reporting issuer (or equivalent) for an order that Amalco cease to be a reporting issuer (or equivalent) under applicable securities laws. Additional information concerning the Amalgamation, including instructions for former Sierra Shareholders to receive the Consideration, is set forth in the notice of annual general and special meeting and information circular of Sierra dated June 23, 2025 available under Sierra's issuer profile on SEDAR+ at The TSX has neither approved nor disapproved of the information contained herein. EARLY WARNING DISCLOSURE The purpose of the Offer was to enable Alpayana to acquire all of the issued and outstanding Sierra Shares. Prior to the Amalgamation and the Preferred Share Acquisition, Alpayana (through Alpayana Canada) held 202,768,502 of the 216,135,842 Sierra Shares outstanding at such time. Following completion of the Amalgamation and the Preferred Share Acquisition, Alpayana Canada holds 202,768,502 of the 202,768,502 outstanding Amalco Common Shares and 13,367,340 of the 13,367,340 outstanding Amalco Preferred Shares. A copy of Alpayana's early warning report to be filed for the privatization can be obtained from Shorecrest Group, the Depositary for the Amalgamation, by telephone at 1-888-637-5789 (North American Toll-Free Number), 647-931-7454 (outside North America) or by email at contact@ Amalco's head office is located at 66 Wellington Street West, TD Bank Tower, Suite 5300, Toronto, Ontario, M5K1E6, Canada. ABOUT ALPAYANA Alpayana Canada is a Canadian wholly-owned subsidiary of Alpayana and was incorporated for the sole purpose of making the offer to purchase all of the issued and outstanding common shares of Sierra. Alpayana is a family-owned private mining company committed to the development and promotion of sustainable and responsible mining. It strives to leave a positive and meaningful legacy by prioritizing the wellbeing of its employees, the communities it impacts and the environment. Alpayana has been operating mines in Peru for over 38 years, has a successful M&A track record, and experience in developing projects with discipline and with a view on long-term intrinsic value. Alpayana has revenues in excess of US$500 million and a robust balance sheet. ABOUT SIERRA METALS INC. Sierra Metals is a Canadian mining company focused on copper production with additional base and precious metals by-product credits at its Yauricocha Mine in Peru and Bolivar Mine in Mexico. Sierra Metals is intent on safely increasing production volume and growing mineral resources. Sierra Metals has recently had several new key discoveries and still has many more exciting brownfield exploration opportunities in Peru and Mexico that are within close proximity to the existing mines. Additionally, Sierra Metals has large land packages at each of its mines with several prospective regional targets providing longer-term exploration upside and mineral resource growth potential. FORWARD-LOOKING INFORMATION CAUTIONARY STATEMENT This news release contains certain forward-looking information (referred to herein as "forward-looking statements"). Forward-looking statements are often, but not always, identified by the use of words such as "anticipate", "believe", "plan", "scheduled", "intend", "objective", "continuous", "ongoing", "estimate", "expect", "may", "will", "project", "should", or similar words suggesting future events, circumstances or outcomes. In particular, this news release contains forward-looking information concerning the anticipated delisting of the Sierra Shares from the Toronto Stock Exchange and the application for an order that Amalco cease to be a reporting issuer in Canada. Forward-looking statements are based upon the opinions and expectations of management of Alpayana and Amalco as at the effective date of such statements. Although Alpayana and Amalco believe the expectations reflected in such forward-looking statements are based upon reasonable assumptions, it can give no assurance that those expectations will prove to have been correct. Forward-looking statements are subject to certain risks and uncertainties that could cause actual events or outcomes to differ materially from those anticipated or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to, such things as the dynamic nature of the industry in which Alpayana and Amalco operate and new laws and regulations (domestic and foreign). Having regard to the various risk factors, readers should not place undue reliance upon the forward-looking statements contained in this news release and such forward-looking statements should not be interpreted or regarded as guarantees of future outcomes. The forward-looking statements contained in this news release are made as of the date hereof and neither Amalco nor Alpayana undertake any obligation to update or to revise any of the included forward-looking statements, except as required by applicable securities laws in force in Canada. The forward-looking statements contained in this news release are expressly qualified by this cautionary statement. For further information, please visit or contact: Investor RelationsSierra Metals Inc.+1 (866) 721-7437info@ SOURCE Sierra Metals Inc. View original content to download multimedia: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Hamilton Spectator
3 hours ago
- Hamilton Spectator
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
VANCOUVER, British Columbia and BOSTON, Aug. 01, 2025 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for patients in need, today announced equity inducement grants to six new non-officer employees consisting of an aggregate of 24,200 share options. All of the foregoing share options were approved by the Compensation Committee of the Company's Board of Directors with an effective date of July 31, 2025 and were granted as inducements material to the employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4). The share options have an exercise price of $30.54 per common share, which is equal to the closing price per share of Xenon's common shares on the grant date of July 31, 2025. The share option grants vest over four years, with 25% vesting on the one-year anniversary of the respective employee's start date and 1/36th of the remaining options vesting monthly thereafter on the last day of each month, subject to such option recipient's continued service relationship with the Company. Each option has a 10-year term and is subject to the terms and conditions of the share option agreement and the terms of the Company's 2025 Inducement Equity Incentive Plan. About Xenon Pharmaceuticals Inc. Xenon Pharmaceuticals (Nasdaq: XENE) is a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics. We are advancing an ion channel product portfolio to address areas of high unmet medical need, including epilepsy and depression. Azetukalner, a novel, highly potent, selective Kv7 potassium channel opener, represents the most advanced, clinically validated potassium channel modulator in late-stage clinical development for multiple indications. For more information, please visit . 'Xenon' and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner. Contacts: For Investors: Chad Fugere Vice President, Investor Relations (857) 675-7275 investors@ For Media: Colleen Alabiso Senior Vice President, Corporate Affairs (617) 671-9238 media@
Hamilton Spectator
3 hours ago
- Hamilton Spectator
Lumine Group Inc. Announces Results for the Three and Six Months Ended June 30, 2025
TORONTO, Aug. 01, 2025 (GLOBE NEWSWIRE) — Lumine Group Inc. ('Lumine Group' or 'the Company') (TSXV:LMN) announces financial results for the three and six months ended June 30, 2025. All amounts referred to in this press release are in US dollars unless otherwise stated. The following press release should be read in conjunction with the Company's unaudited condensed consolidated interim financial statements for the three and six months ended June 30, 2025, and management's discussion and analysis ('MD&A') for the three and six months ended June 30, 2025, which can be found on SEDAR+ at . Additional information about Lumine Group is also available on SEDAR+ and on Lumine Group's website . Q2 2025 Headlines: Year-to-Date Q2 2025 Headlines: Total revenue for the three months ended June 30, 2025 is $184.0 million, an increase of 13% or $21.1 million, compared to $162.8 million for the same period in 2024. For the six months ended June 30, 2025, total revenue was $362.6 million, an increase of 19%, or $58.7 million, compared to $303.9 million for the same period in 2024. The increase for the three and six months compared to the same period in the prior year is attributable to revenues from new acquisitions. The Company experienced organic growth of 9% and 2%, respectively, for the three and six months ended June 30, 2025, or 6% and 1% after adjusting for the impact of changes in the valuation of the US dollar against most major currencies in which the Company transacts business. For acquired companies, organic growth is calculated as the difference between actual revenues achieved by each business in the financial period following acquisition, compared to the estimated revenues they achieved in the corresponding financial period preceding the date of acquisition by the Company. Organic growth is not a standardized financial measure and might not be comparable to measures disclosed by other issuers. Operating income for the three months ended June 30, 2025 was $62.7 million, an increase of 71%, or $26.1 million, compared to $36.6 million for the same period in 2024. Operating income for the six months ended June 30, 2025 was $122.2 million, an increase of 51%, or $41.1 million, compared to $81.1 million for the same period in 2024. The increase for the three and six month periods is primarily attributable to growth from acquisitions. Operating income is not a standardized financial measure and might not be comparable to measures disclosed by other issuers. See 'Non-IFRS Measures'. Net income for the three months ended June 30, 2025 was $23.6 million compared to net loss of $2.2 million for the same period in 2024. Net income for the six months ended June 30, 2025 was $44.3 million compared to net loss of $306.6 million for the same period in 2024. The increase in net income for the three and six months is primarily attributable to growth from acquisitions and the Mandatory Conversion of Preferred and Special Securities on March 25, 2024 such that no further preferred and special securities expense was booked in the subsequent quarters. For the three months ended June 30, 2025, CFO increased $68.7 million to $78.4 million compared to $9.7 million for the same period in 2024 representing an increase of 705%. For the six months ended June 30, 2025, CFO increased $73.8 million to $118.5 million compared to $44.7 million for the same period in 2024 representing an increase of 165%. The primary reason for the increase is that CFO includes the impact of changes in non-cash operating assets and liabilities exclusive of effects of business combinations or changes in non-cash operating working capital ('NCOWC') which improved during the three and six months ended June 30, 2025 compared to the same period prior year, as well as higher operating income. For the three months ended June 30, 2025, FCFA2S increased $69.6 million to $72.4 million compared to $2.8 million for the same period in 2024. For the six months ended June 30, 2025, FCFA2S increased $75.8 million to $107.4 million compared to $31.5 million for the same period in 2024. The increase in the three and six months ended June 30, 2025 is driven by higher CFO compared to the same periods in 2024. FCFA2S is a non-IFRS Measure. See 'Non-IFRS Measures'. Non-IFRS Measures Operating income (loss) refers to income (loss) before income taxes, amortization of intangible assets, redeemable Preferred and Special Share expense, gain on bargain purchase, and finance and other expenses (income). We believe that operating income is useful supplemental information as it provides an indication of the profitability of the Company related to its core operations. Operating income (loss) is not a recognized measure under IFRS and may not be comparable to similar financial measures disclosed by other issuers. Accordingly, readers are cautioned that operating income (loss) should not be construed as an alternative to net income (loss). The following table reconciles operating income to net income: Free cash flow available to shareholders ''FCFA2S'' refers to net cash flows from operating activities less interest paid on lease obligations, interest paid on bank debt, transaction costs on bank debt, repayments of lease obligations, interest, dividends and other proceeds received, and property and equipment purchased net of proceeds from disposal. The Company believes that FCFA2S is useful supplemental information as it provides an indication of the uncommitted cash flow that is available to shareholders if Lumine Group does not make any acquisitions, or investments, and does not repay any debts. While the Company could use the FCFA2S to pay dividends or repurchase shares, the Company's objective is to invest all of its FCFA2S in acquisitions which meet the Company's hurdle rate. FCFA2S is not a recognized measure under IFRS and may not be comparable to similar financial measures disclosed by other issuers. Accordingly, readers are cautioned that FCFA2S should not be construed as an alternative to net cash flows from operating activities. The following table reconciles FCFA2S to net cash flows from operating activities: Forward Looking Statements Certain statements herein may be 'forward looking' statements that involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of Lumine Group or the industry to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Forward looking statements involve significant risks and uncertainties, should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether or not such results will be achieved. A number of factors could cause actual results to vary significantly from the results discussed in the forward looking statements. These forward looking statements reflect current assumptions and expectations regarding future events and operating performance and are made as of the date hereof and Lumine Group assumes no obligation, except as required by law, to update any forward looking statements to reflect new events or circumstances. About Lumine Group Inc. Lumine Group acquires, strengthens, and grows, vertical market software businesses in the communications and media industry. Learn more at . For further information: David Nyland Chief Executive Officer Lumine Group investors@ +1-437-353-4910 Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Condensed Consolidated Interim Statements of Financial Position (In thousands of USD. Due to rounding, numbers presented may not foot.) Condensed Consolidated Interim Statements of Income (Loss) (In thousands of USD, except per share amounts. Due to rounding, numbers presented may not foot.) Condensed Consolidated Interim Statements of Comprehensive Income (Loss) (In thousands of USD. Due to rounding, numbers presented may not foot.) Condensed Consolidated Interim Statement of Changes in Equity (In thousands of USD. Due to rounding, numbers presented may not foot.) Condensed Consolidated Interim Statement of Changes in Equity (In thousands of USD. Due to rounding, numbers presented may not foot.) Condensed Consolidated Interim Statements of Cash Flows (In thousands of USD. Due to rounding, numbers presented may not foot.) 1 See 'Non-IFRS Measures'.
